USA · PI Dr. Muller · activated
Patients
21
Active
0
Serious AEs
0
Open QA
1
Aged queries
0
Luna users
0
Studies & contracts
Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II · study completed · contract executed · 244500 USD
Patients (21)
705-1011 ›
screened
705-1018 ›
withdrawn
705-1031 ›
withdrawn
705-1058 ›
screened
705-1059 ›
completed
705-1112 ›
screened
705-1186 ›
withdrawn
705-1199 ›
completed
705-1243 ›
screened
705-1280 ›
completed
705-1281 ›
completed
705-1282 ›
completed
705-1292 ›
completed
705-1303 ›
completed
705-1310 ›
completed
705-1349 ›
completed
705-1377 ›
withdrawn
705-1382 ›
completed
705-1393 ›
completed
705-1421 ›
screened
705-1431 ›
completed
Safety — 27 AEs, 0 serious
No serious adverse events.
QA findings (1 open)
open
major
PROTOCOL VIOLATION: PROTOCOL ENTRY CRITERIA NOT MET (subject 705-1382, 2013-05-13)
Visits & payments
Nothing scheduled.
☾ Luna participants
No Luna participants here yet.